Previous studies have suggested that soy intake may carry beneficial effects on glycemic control, but human intervention studies have yielded mixed results. A recent meta-analysis of 24 trials and more than 1,500 subjects found that soy consumption does not significantly affect measures of glycemic control. Researchers noted that there was …
Read More »Yearly Archives: 2011
Carb Counting vs. Glycemic Load to Determine Insulin Bolus?
How many carbs you eat might be less important for your blood sugar than your food’s glycemic load….
Read More »Old Mitochondria May be Responsible for Neuropathy in the Extremities
The finding may eventually lead to new ways to fight neuropathy, a condition that often accompanies other diseases including HIV/AIDS, diabetes and circulatory disorders….
Read More »Identifying Patients Who Can Benefit from Preventive Interventions
A1c and cardiovascular risk scores identify those who can benefit from preventive interventions, according to the ADDITION study….
Read More »Physician’s Empathy Associated with Positive Clinical Outcomes in Diabetic Patients
A physician’s empathy is an important factor associated with clinical competence….
Read More »Predicting the Best Response from Metformin via Genetic Markers
Common variants are associated with glycemic response to metformin in Type 2 diabetes….
Read More »Otelixizumab Developed by GSK and Tolerx Fails in Type 1 Diabetes Study
Tolerx, Inc., and GlaxoSmithKline (GSK) announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12 in patients with new-onset autoimmune Type 1 diabetes….
Read More »Study Finds Three Times-a-Week Insulin Improves Glucose Levels
An alternate form of insulin that is longer lasting may be approved in upcoming years….
Read More »Blood Pressure Drug Delays Kidney Disease in Diabetes Patients
The drug pressure-reducing medication olmesartan, brand name Benicar, could increase the time before any kidney problems were evident by 23 percent. But experts are concerned about higher deaths from heart problems….
Read More »Valsartan (ARB) Improves Beta-Cell Function and Insulin Sensitivity
Valsartan treatment increased glucose-stimulated insulin release and insulin sensitivity in normotensive subjects with IGM….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.